The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

According to a recent study, nearly three in four Americans are overweight. Worse, this report predicts that for decades to ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss.

Significant periods of weight regain were observed at eight, 12, and 20 weeks after stopping the anti-obesity medications. The analysis revealed that the weight rebound typically continued for an ...

New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge ...

More studies are needed, but patients should consider adding exercise and ensure adequate protein intake to maximize the ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.